Pott's puffy tumor: An unusual complication of rhino-orbito-cerebral mucormycosis

Ananth P Abraham1, Abi Manesh2, Soumya Regi3

  • 1Departments of Neurological Sciences, Christian Medical College Vellore, Tamil Nadu, India.

PubMed
Abstract

Insights

Rhino-orbito-cerebral mucormycosis with Pott's puffy tumor (ROCM-PPT) is a rare complication. Aggressive surgical debridement and antifungal treatment led to good outcomes in COVID-19 patients.

Area of Science:

  • Infectious Diseases
  • Neurosurgery
  • Ophthalmology

Background:

  • Rhino-orbito-cerebral mucormycosis (ROCM) is a severe fungal infection.
  • Pott's puffy tumor (PPT) is a rare, delayed complication of ROCM, particularly noted during the COVID-19 pandemic.

Purpose of the Study:

  • To detail the clinicoradiological characteristics of ROCM with PPT (ROCM-PPT).
  • To evaluate surgical outcomes for patients with ROCM-PPT.

Main Methods:

  • Analysis of nine patients diagnosed with ROCM-PPT between March 2020 and December 2021.
  • Review of clinical data, radiological findings, histopathology, surgical procedures, and patient outcomes.
  • Comparison of frontal sinus anatomy between ROCM-PPT patients and controls.

Main Results:

  • ROCM-PPT occurred in 3.2% of ROCM patients; 66.7% were male, median age 54.
  • Diabetes mellitus (88.9%) and prior COVID-19 (77.8%) were common comorbidities.
  • All patients showed osteomyelitis, subperiosteal abscess, and dural enhancement; all underwent debridement and antifungal therapy.
  • Symptomatic improvement was observed in all patients at a median follow-up of 21 months, with disease resolution in 75% of those with follow-up imaging.

Conclusions:

  • ROCM-PPT is a rare but significant delayed complication of mucormycosis, with increased incidence during the COVID-19 pandemic.
  • Prompt and aggressive surgical debridement of infected bone combined with antifungal therapy is crucial for favorable patient outcomes.